1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Cost-effectiveness: new trials by email Literature Review of Cost-effectiveness trials Research Report on Cost-effectiveness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-acting G-CSF for Febrile Neutropenia long-acting granulocyte colony stimulating factor, Short-term granulocyte colony stimulating factor - Epithelial Ovarian Cancer, Colony Stimulating Factors | Phase 3 | Unknown | Lei Li | 556 | 2018-11-10 | 2018-11-14 |
| Efficacy and Cost of State Quitline Policies Multi-session telephone counseling, NRT patches - Smoking Cessation, Tobacco Use Cessation | Phase 3 | Completed | Kaiser Permanente | 4614 | 2000-06-01 | 2011-05-02 |
Carcinoma, Ovarian Epithelial (1) · Febrile Neutropenia (1) · Smoking (1) · Smoking Cessation (1) · Tobacco Use Cessation (1)
Adnexal Diseases (1) · Agranulocytosis (1) · Behavior (1) · Carcinoma (1) · Cytopenia (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Health Behavior (1) · Hematologic Diseases (1)
Kaiser Permanente (1) · Lei Li (1)
China (1) · United States (1)
Jack F. Hollis, PhD (1) · Lei Li, M.D. (1) · Michael J Stark, PhD (1) · Timothy A McAfee, MD (1)
R01CA086242 (1)